The latest news from Lupus Europe Web site./cms/contents/content/lupus/news/newsentries/epratuzumabreceivedu/default.aspx20.01.2010 00:00:00 +01:00Epratuzumab receives U.S. patent/cms/contents/content/lupus/news/newsentries/julianlennonfundsonr/default.aspx07.12.2009 00:00:00 +01:00Julian Lennon: Funds on ResearchHuman Genome Sciences, Inc. and GlaxoSmithKline Plc said on November 2, 2009, that Benlysta, or belimumab, met its primary endpoint in the second of /cms/contents/content/lupus/news/newsentries/hgsandgsknewlupusdru/default.aspx02.11.2009 00:00:00 +01:00HGS and GSK: New lupus drug Benlysta meets primary endpointMore Than a Dozen Different Genes May Play a Role in Causing Lupus At least a dozen or more genes may help explain what causes lupus, according to /cms/contents/content/lupus/news/newsentries/geneticlinktolupus/default.aspx19.10.2009 00:00:00 +02:00Genetic Link to Lupushttp://www.lupus-europe.org:80/news/rss.feedLupus Europe News